|
Peptide Therapeutic for Promoting Tumor Cell DNA Damage and Natural Killer Cell-Mediated Metastatic Surveillance
This invention is a cell-penetrating peptide therapeutic that blocks nuclear epidermal growth factor receptor (nEGFR) localization to induce tumor regression and natural killer (NK) cell-mediated metastatic surveillance of triple-negative breast cancer (TNBC). Mouse model studies demonstrated that inhibiting nEGFR trafficking induces NK cell surveillance,...
Published: 7/28/2026
|
Updated: 7/28/2026
|
Inventor(s): Joyce Schroeder, Ryan Hecksel
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Oncology, Technology Classifications > Life Sciences > Therapeutics
|
